Found 7318 matches for
The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
Our Maternal & Fetal Health research covers the following research groups: Lactation, Intelligent Imaging in Fetal Health, The Oxford Safer Pregnancy Alliance (OSPREA), Oxford Centre for Labour Monitoring, Placental Imaging, the INGR1D Study and Pre-eclampsia.
Our Reproductive Medicine & Genetics research covers the following research groups: Assisted Reproductive Technology (ART); Endometriosis; Fertility Preservation; Miscarriage; Oocytes and Ovaries; Pain in Women; Rhino Fertility Project and Sperm.
Our Global Health research covers the following research groups: Cardiovascular Disease; Deep Medicine; INTERGROWTH 21st; ME/CFS; Multimorbidity; Neurodevelopment; The Oxford Maternal & Perinatal Health Institute (OMPHI); Oxford University Global Surgery Group, SMARThealth Pregnancy and Urban Health.
Our Cancer research covers the following research groups: Cervical Neoplasia (developing therapeutics to eradicate HPV infections in women), Nanoparticles in Cancer (focussing on the use of nanoparticles in cancer for therapy, imaging or drug delivery) and Ovarian Cancer (exploring the molecular mechanisms that drive Ovarian Cancer cell growth and examining which targeted therapies can be utilised to improve treatment).